medicare glp-1 coverage obesity weight loss drugs: Who can get GLP-1s for $50 a month? The GLP-1 Access Gap: Mapping

Since December 2008, the United States Food and Drug Administration (FDA) regulatory guidance for industry mandated cardiovascular outcome trials (CVOTs) for cardiovascular safety of novel antidiabetic agents to ensure their cardiovascular safety

Findings in different studies indicate that Garcinia cambogia and Glucomannan therapy in individuals with overweight or obesity (across varying ages, sexes, and metabolic conditions) led to meaningful improvements in body composition and metabolic health

The basic formula Concentration (mg/mL) = Total peptide (mg) Water volume (mL) For a 70mg vial with 3mL water: 70 3 = 23.33 mg/mL Volume to draw (mL) = Desired dose (mg) Concentration (mg/mL) For 2.33mg dose at 23.33 mg/mL: 2.33 23.33 = 0.10mL = 10 units on an insulin syringe Common vial sizes and calculations 42mg vial with 1.8mL water: Concentration: 23.33 mg/mL Standard dose (2.33mg): 10 units Conservative dose (1.165mg): 5 units Vial provides approximately 18 doses at standard protocol 70mg vial with 3mL water: Concentration: 23.33 mg/mL Standard dose (2.33mg): 10 units Conservative dose (1.165mg): 5 units Vial provides approximately 30 doses at standard protocol 70mg vial with 2mL water (higher concentration): Concentration: 35 mg/mL Standard dose (2.33mg): 6.7 units (round to 7) Conservative dose (1.165mg): 3.3 units (round to 3) Smaller volumes make precise measurement more difficult The SeekPeptides peptide calculator automates these calculations for any vial size and desired dose

Corsetti V, Florenzano F, Atlante A, et al